Toshihide Yokoyama - Concepedia

Author

Toshihide Yokoyama

Kurashiki Central Hospital ORCID

Also Known As

Reiko Kaji, T Yokoyama, T. Yokoyama, TOSHIHIDE YOKOYAMA, Toshihide YOKOYAMA, Toshihide Yokoyama, Yokoyama, Toshihide

240

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

Kurashiki Central Hospital National Hospital Organization Kobe City Medical Center General Hospital Osaka City General Hospital Osaka International Cancer Institute

About

Toshihide Yokoyama is an author at Kurashiki Central Hospital specializing in medicine, lung cancer, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	28	1K
2	Health Sciences	5	5	176
3	Allergy	2	2	57
4	Anesthesia	2	2	91
5	Natural Sciences	1	1	30

Toshihide Yokoyama

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial Tony Mok, Yi‐Long Wu, Iveta Kudaba, The Lancet	2019	3.2K
TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells Katsura Nozawa, Eri Kawabata-Shoda, Hitoshi Doihara, Proceedings of the National Academy of Sciences	2009	397
Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung Cancer Kohsuke Isomoto, Koji Haratani, Hidetoshi Hayashi, Clinical Cancer Research	2020	233
A Phase 2 Study of Atezolizumab for Pretreated NSCLC With Idiopathic Interstitial Pneumonitis Satoshi Ikeda, Terufumi Kato, Hirotsugu Kenmotsu, Journal of Thoracic Oncology Translational MedicineAntibioticsPretreated NsclcPathologyPharmacotherapy	2020	96
QGP-1 cells release 5-HT via TRPA1 activation; a model of human enterochromaffin cells Hitoshi Doihara, Katsura Nozawa, Ryosuke Kojima, Molecular and Cellular Biochemistry Trpa1 ActivationQgp-1 CellsSignal TransductionMolecular PhysiologySignaling Pathway	2009	70
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L) Hiroyuki Yamaguchi, Kazushige Wakuda, Minoru Fukuda, Journal of Thoracic Oncology	2021	67
Effects of novel TRPA1 receptor agonist ASP7663 in models of drug-induced constipation and visceral pain Ryosuke Kojima, Katsura Nozawa, Hitoshi Doihara, European Journal of Pharmacology Molecular PharmacologyVisceral PainHealth SciencesPain MedicineMedicine	2013	64
Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status Satoshi Ikeda, Hiroshige Yoshioka, Satoshi Ikeo, BMC Cancer	2017	60
TRPA1 agonists delay gastric emptying in rats through serotonergic pathways Hitoshi Doihara, Katsura Nozawa, Eri Kawabata-Shoda, Naunyn-Schmiedeberg s Archives of Pharmacology Molecular PharmacologyGastrointestinal PharmacologyMedicinePhysiologyGastroenterology	2009	58
Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non–small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study Hayato Kawachi, Motohiro Tamiya, Akihiro Tamiya, Investigational New Drugs Metastatic SitesHigh Pd-l1 ExpressionMedicineImmunologyPathology	2019	54

Page 1